| Dr D A Lopez, MD | |
|
230 Prospect Pl, Ste 260, Coronado, CA 92118-1987 | |
| (619) 437-1146 | |
| (619) 437-1912 |
| Full Name | Dr D A Lopez |
|---|---|
| Gender | Male |
| Speciality | Dermatology - Dermatopathology |
| Location | 230 Prospect Pl, Coronado, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649273293 | NPI | - | NPPES |
| 00G104110 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | G10411 (California) | Primary |
| Entity Name | Charlene V. Kakimoto, Md, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083104012 PECOS PAC ID: 4880940956 Enrollment ID: O20180702003354 |
News Archive
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
One of the defining characteristics of solid tumors is the development of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial research team, led by investigators from the Siteman Center of Cancer Nanotechnology Excellence, has developed a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.
Care Oncology Clinic, an independent, private organisation providing oncology treatments, announces today the launch of its first clinic on London's Harley Street. Delivered by leading oncologists and palliative care doctors, the clinic is the first of its kind, specifically set up to offer a specialised cancer treatment by targeting the energy requirements of cancer cells using existing medicines that are already licensed for this purpose, have an acceptable safety profile and are low cost. Designed for patients for whom the standard oncology treatment regime is not available, viable, tolerable or providing benefit, this is a new option for treating these cancer patients.
To the careful observer, a person's face has long provided insight into what is going on beneath the surface. Now, with the assistance of a web camera and software algorithms, the face can also reveal whether or not an individual is experiencing atrial fibrillation, a treatable but potentially dangerous heart condition.
In a letter to the Minister for Health and Social Services Jane Hutt, Dr Andrew Dearden - the chairman the BMA's GP Committee for Wales - has expressed his bitter disappointment in the breakdown of negotiations between the BMA and the Welsh Assembly Government on the future of community hospitals in Wales
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr D A Lopez, MD 230 Prospect Pl, Ste 260, Coronado, CA 92118-1987 Ph: (619) 437-1146 | Dr D A Lopez, MD 230 Prospect Pl, Ste 260, Coronado, CA 92118-1987 Ph: (619) 437-1146 |
News Archive
Trimeris, Inc. ("Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co., Ltd. and RTM Acquisition Company ("Arigene" and "Purchaser," respectively) (the "Merger Agreement"), Arigene has informed Trimeris through counsel that Arigene intends to terminate the tender offer for all of Trimeris' outstanding shares of common stock because Arigene was unable to secure sufficient financing for purposes of funding the tender offer. The tender offer expired on Monday, December 28, 2009.
One of the defining characteristics of solid tumors is the development of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial research team, led by investigators from the Siteman Center of Cancer Nanotechnology Excellence, has developed a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.
Care Oncology Clinic, an independent, private organisation providing oncology treatments, announces today the launch of its first clinic on London's Harley Street. Delivered by leading oncologists and palliative care doctors, the clinic is the first of its kind, specifically set up to offer a specialised cancer treatment by targeting the energy requirements of cancer cells using existing medicines that are already licensed for this purpose, have an acceptable safety profile and are low cost. Designed for patients for whom the standard oncology treatment regime is not available, viable, tolerable or providing benefit, this is a new option for treating these cancer patients.
To the careful observer, a person's face has long provided insight into what is going on beneath the surface. Now, with the assistance of a web camera and software algorithms, the face can also reveal whether or not an individual is experiencing atrial fibrillation, a treatable but potentially dangerous heart condition.
In a letter to the Minister for Health and Social Services Jane Hutt, Dr Andrew Dearden - the chairman the BMA's GP Committee for Wales - has expressed his bitter disappointment in the breakdown of negotiations between the BMA and the Welsh Assembly Government on the future of community hospitals in Wales
› Verified 9 days ago
Dr. Charlene Vimala Kakimoto, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 230 Prospect Pl, Ste. 260, Coronado, CA 92118 Phone: 619-437-1146 Fax: 619-437-1146 | |
Dr. Nancy B. Murray, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 230 Prospect Pl, Ste 260, Coronado, CA 92118 Phone: 619-437-1146 Fax: 619-437-1912 | |
Dr. Michael J Yablonsky, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 230 Prospect Pl, Suite 260, Coronado, CA 92118 Phone: 619-437-1146 Fax: 619-437-1912 | |
Dr. Ann M. Siefert, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1317 Ynez Pl Ste A, Coronado, CA 92118 Phone: 858-554-8645 |